SEC Charges Microcap Company in Pump-and-Dump Scheme

The SEC charged a microcap company and related executives with orchestrating a pump-and-dump scheme, falsely promoting the company and its valuation, filing misleading statements and defrauding investors "out of approximately $8 million while generating millions of dollars in ill-gotten proceeds from sales." 

In a Complaint filed in the United States District Court for the District of Columbia, the SEC alleged that the defendants engaged in fraudulent activities to artificially inflate the stock price of the company, which traded on the OTC Pink market. The SEC contended that one of the executives used nominee individuals (including personal friends) and a shell company to secretly gain control of a substantial stock position, converting a $50,000 note into one billion newly issued shares of the company's stock.

The SEC alleged that the defendants falsely promoted the company as a pioneering entity in the psilocybin mushroom market, making misleading and baseless claims about partnerships with foreign firms and a purported valuation of $1 billion by an independent third party. The SEC claimed that after inflating the stock price through public statements and promotional efforts, the executives arranged for the sale of the shares. The SEC also claimed that the defendants transferred approximately $3.4 million in proceeds to an entity controlled by one of the executives, who then utilized the funds for personal expenditures, including luxury items and other unrelated costs.

The SEC charged the defendants with violations of SEA Section 10(b) ("Regulation of the use of manipulative and deceptive devices"), SEA Rule 10b-5 ("Employment of manipulative and deceptive devices") and SA Section 17(a) ("Fraudulent Interstate Transactions").

The SEC is seeking (i) permanent injunctive relief, (ii) disgorgement of the alleged ill-gotten gains, (iii) civil penalties against the defendants and (iv) additional measures to bar the executives from serving as officers or directors of any publicly traded company in the future.

Tags